RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/17395341http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/17395341http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/17395341http://www.w3.org/2000/01/rdf-schema#comment"Recombinant botulinum Hc (rBoNT Hc) vaccines for serotypes C1 and D were produced in the yeast Pichia pastoris and used to determine protection against four distinct BoNT C and D toxin subtypes. Mice were vaccinated with rBoNT/C1 Hc, rBoNT/D Hc, or with a combination of both vaccines and challenged with BoNT C1, D, C/D, or D/C toxin. Mice receiving monovalent vaccinations were partially or completely protected against homologous toxin and not protected against heterologous toxin. Bivalent vaccine candidates completely survived challenges from all toxins except D/C toxin. These results indicate the recombinant C1 and D Hc vaccines are not only effective in a monovalent formula but offer complete protection against both parental and C/D mosaic toxin and partial protection against D/C mosaic toxin when delivered as a bivalent vaccine."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.org/dc/terms/identifier"doi:10.1016/j.vaccine.2007.02.081"xsd:string
http://purl.uniprot.org/citations/17395341http://purl.org/dc/terms/identifier"doi:10.1016/j.vaccine.2007.02.081"xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Smith T.J."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Smith T.J."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Smith L.A."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Smith L.A."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Meagher M.M."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Meagher M.M."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Montgomery V.A."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Montgomery V.A."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Webb R.P."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Webb R.P."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Wright P.M."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/author"Wright P.M."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/date"2007"xsd:gYear
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/date"2007"xsd:gYear
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/name"Vaccine"xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/name"Vaccine"xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/pages"4273-4282"xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/pages"4273-4282"xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/title"Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins."xsd:string
http://purl.uniprot.org/citations/17395341http://purl.uniprot.org/core/title"Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins."xsd:string